2 enrolling by invitation. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 2 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Neuroblastoma: new trials by email Literature Review of Neuroblastoma trials Research Report on Neuroblastoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma GPC2 CAR T cells - Refractory Neuroblastoma, Relapsed Neuroblastoma | Phase 1 | Enrolling by invitation | Stephan Grupp MD PhD | 45 | 2023-05-23 | 2026-08-14 |
| The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells cytokine induced killer cells - Cholangiocarcinoma, Neuroblastoma | Phase 1 / Phase 2 | Enrolling by invitation | Siriraj Hospital | 20 | 2009-04-17 | 2025-02-10 |
Cholangiocarcinoma (1) · Retinoblastoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Neuroepithelial (2) · Neuroectodermal Tumors (2) · Neuroectodermal Tumors, Primitive (2) · Neuroectodermal Tumors, Primitive, Peripheral (2) · Adenocarcinoma (1) · Carcinoma (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Eye Neoplasms (1) · Neoplasms by Site (1)
Siriraj Hospital (1) · Stephan Grupp MD PhD (1)
Thailand (1) · United States (1)
Adisak Wongkajornsilp, M.D., Ph.D. (1) · Lisa Wray, MD (1)
R37CA282041 (1)